scispace - formally typeset
N

Ningyan Zhang

Researcher at University of Texas Health Science Center at Houston

Publications -  48
Citations -  2774

Ningyan Zhang is an academic researcher from University of Texas Health Science Center at Houston. The author has contributed to research in topics: Antibody & Monoclonal antibody. The author has an hindex of 18, co-authored 48 publications receiving 2055 citations. Previous affiliations of Ningyan Zhang include Schering-Plough & Merck & Co..

Papers
More filters
Journal ArticleDOI

TREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function

TL;DR: TREM2 is demonstrated as a microglial Aβ receptor transducing physiological and AD-related pathological effects associated with Aβ, and TREM2 interaction with its signaling adaptor DAP12 is enhanced by A β, regulating downstream phosphorylation of SYK and GSK3β.
Journal ArticleDOI

Improving tolerance of Candida antarctica lipase B towards irreversible thermal inactivation through directed evolution

TL;DR: Direct evolution is used to create CALB mutants with improved resistance towards irreversible thermal inactivation and over a 20-fold increase in half-life at 70 degrees C compared with the wild-type CALB (WT-CALB).
Journal ArticleDOI

Trastuzumab Triggers Phagocytic Killing of High HER2 Cancer Cells In Vitro and In Vivo by Interaction with Fcγ Receptors on Macrophages

TL;DR: Results indicated that activation of macrophages in combination with trastuzumab can serve as a therapeutic strategy for treating high HER2 breast cancer by boosting ADCP killing of cancer cells.